Personal Products company Godrej Consumer Products announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Q4FY25 Consolidated organic sales grew by 7% in Rs terms YoY on the back of underlying volume growth of 6%. Standalone business underlying volume grew by 4%, sales grew by 8% YoY. Indonesia underlying volume grew by 5%, sales grew by 1% in Rs terms and 1% in constant currency terms, YoY. Africa, USA, and Middle East organic sales grew 12% in constant currency terms and 23% in Rs terms, YoY. Latin America and Others sales grew in constant currency terms, by 2%, but declined by 11% in Rs terms, YoY. Q4FY25 Consolidated EBITDA grew by 1% YoY. FY25 Financial Highlights: FY25 Consolidated organic underlying volume grew at 4%, sales grew by 4% in Rs terms impacted by devaluation, constant currency growth of 8% YoY. Standalone business underlying volume grew by 5%, sales grew by 7% YoY. Indonesia underlying volume grew by 6%, sales grew by 5% in Rs terms and 8% in constant currency terms, YoY. Africa, USA, and Middle East organic sales grew by 1% in constant currency terms but declined by 7% in Rs terms, YoY on the back of planned trade down stocking actions. Latin America and Others sales grew in constant currency terms, by 46%, and by 28% in Rs terms, YoY. FY25 Consolidated EBITDA grew by 2% YoY. Sudhir Sitapati, Managing Director, CEO, GCPL, said: We delivered a sequentially improving performance in Q4FY25, despite market conditions remaining the same. Our Consolidated organic volumes for Q4FY25 grew by 6%, led by the India business growing volumes at 4% and Indonesia growing volumes at 5%. This led to full-year organic volume growth delivery at 4% for our consolidated business, 5% for India and 6% for Indonesia. Our Consolidated organic revenue growth for Q4 and FY25 stood at 7% and 4% respectively. Demand conditions in India have continued to be impacted by headwinds in urban consumption. Surge in palm oil prices by more than 50% is negatively impacting our EBITDA margin. Our reported Standalone EBITDA margin at 22.6% is lower than our normative margin. However, buoyed by a good season, we had a blockbuster performance in Household Insecticides which grew volumes in strong double digit. Our categories of Air Fresheners, Laundry Liquids, etc. have continued to deliver strong underlying volume growth. This helped deliver 4% volume growth on top of a 4% pricing growth led largely by soaps. The volume growth on the non-soaps’ portfolio was high single digit with soaps volume growth impacted by volume-price rebalancing. In Indonesia, we continue to consistently deliver healthy performance with 5% volume growth and EBITDA margin expansion. In organic terms, Africa, USA and the Middle East sales grew by a strong 23% in Rs terms and delivered 17% EBITDA margin resulting in the fifth consecutive quarter of profit and margin expansion. We are on track in our journey to reduce wasted cost and are deploying this to drive profitable and sustainable volume growth across our portfolio through category development. We remain committed to our purpose of bringing the goodness of health and beauty to consumers in emerging markets. Result PDF